Sao Paulo | Reuters – Corteva Agriscience said on Aug. 9 it will start selling biotech soybean seeds in Brazil, as it seeks to bolster its presence in the world’s largest producer of the oilseed and tackle German rival Bayer AG.
Corteva said its Enlist soybean seeds can resist three weed killers including glyphosate, ammonium glufosinate and the company’s own new formula containing 2,4-D choline salt.
“We want to give farmers freedom of choice, an option for local growers since there was basically only one company operating in the soy biotechnology market in Brazil,” Roberto Hun, Corteva’s president for Brazil and Paraguay, said in an interview.
Read Also
Alberta crop conditions improve: report
Varied precipitation and warm temperatures were generally beneficial for crop development across Alberta during the week ended July 8, according to the latest provincial crop report released July 11.
The company will compete directly with Bayer’s Intacta genetically modified soy technology, which similarly resists weed-killers and insects.
Hun said use of Enlist in the United States exceeded expectations. Quick adoption by farmers led 35 percent of the U.S. soy area to be cultivated with the product within three years of its launch, he said.
Christian Pflug, head of Enlist technology for Brazil and Paraguay, said local farmers would be able to raise soy yields by 2 to 5 percent if they embrace the technology. The company hopes one-third of Brazil’s soybean area is planted with its biotech seeds within five years.
As part of its Enlist product line, Corteva also plans to launch another genetically modified soy seed, Conkesta, in Brazil. The company says it can resist the same three weed killers as well as some types of caterpillars – a common plague of tropical agriculture.
The Conkesta launch is pending EU approval of that specific technology, as the bloc imports soy and soymeal from Brazil, executives said. Brazil’s biggest soybean buyer is China, where Enlist and Conkesta products have been cleared by regulatory authorities, executives said.
